Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 144

1.

Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke.

Dietel B, Cicha I, Kallmünzer B, Tauchi M, Yilmaz A, Daniel WG, Schwab S, Garlichs CD, Kollmar R.

Exp Neurol. 2012 Oct;237(2):379-87. doi: 10.1016/j.expneurol.2012.06.019. Epub 2012 Jun 27.

PMID:
22750328
2.

Decreased focal inflammatory response by G-CSF may improve stroke outcome after transient middle cerebral artery occlusion in rats.

Sehara Y, Hayashi T, Deguchi K, Zhang H, Tsuchiya A, Yamashita T, Lukic V, Nagai M, Kamiya T, Abe K.

J Neurosci Res. 2007 Aug 1;85(10):2167-74.

PMID:
17497673
3.

Different treatment settings of Granulocyte-Colony Stimulating Factor and their impact on T cell-specific immune response in experimental stroke.

Dietel B, Cicha I, Achenbach S, Kollmar R, Garlichs C, Tauchi M.

Immunol Lett. 2014 Mar-Apr;158(1-2):95-100. doi: 10.1016/j.imlet.2013.12.006. Epub 2013 Dec 12.

PMID:
24333341
4.

Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.

Sevimli S, Diederich K, Strecker JK, Schilling M, Klocke R, Nikol S, Kirsch F, Schneider A, Schäbitz WR.

Exp Neurol. 2009 Jun;217(2):328-35. doi: 10.1016/j.expneurol.2009.03.018. Epub 2009 Mar 28.

PMID:
19332060
5.

A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF).

Schäbitz WR, Krüger C, Pitzer C, Weber D, Laage R, Gassler N, Aronowski J, Mier W, Kirsch F, Dittgen T, Bach A, Sommer C, Schneider A.

J Cereb Blood Flow Metab. 2008 Jan;28(1):29-43. Epub 2007 Apr 25.

PMID:
17457367
6.

Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia.

Schäbitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Schölzke MN, Sommer C, Schwab S.

Stroke. 2003 Mar;34(3):745-51. Epub 2003 Feb 13.

PMID:
12624302
7.

The anti-inflammatory role of granulocyte colony-stimulating factor in macrophage-dendritic cell crosstalk after Lactobacillus rhamnosus GR-1 exposure.

Martins AJ, Spanton S, Sheikh HI, Kim SO.

J Leukoc Biol. 2011 Jun;89(6):907-15. doi: 10.1189/jlb.0810445. Epub 2011 Mar 8.

PMID:
21385950
8.

Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction.

Naito K, Anzai T, Sugano Y, Maekawa Y, Kohno T, Yoshikawa T, Matsuno K, Ogawa S.

J Immunol. 2008 Oct 15;181(8):5691-701.

10.

Effects of G-CSF treatment on neutrophil mobilization and neurological outcome after transient focal ischemia.

Strecker JK, Sevimli S, Schilling M, Klocke R, Nikol S, Schneider A, Schäbitz WR.

Exp Neurol. 2010 Mar;222(1):108-13. doi: 10.1016/j.expneurol.2009.12.012. Epub 2009 Dec 21.

PMID:
20026112
11.

GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.

Eksioglu EA, Mahmood SS, Chang M, Reddy V.

Exp Hematol. 2007 Aug;35(8):1163-71. Epub 2007 Jun 11.

PMID:
17562355
12.

The hematopoietic factor granulocyte-colony stimulating factor improves outcome in experimental spinal cord injury.

Pitzer C, Klussmann S, Krüger C, Letellier E, Plaas C, Dittgen T, Kirsch F, Stieltjes B, Weber D, Laage R, Martin-Villalba A, Schneider A.

J Neurochem. 2010 May;113(4):930-42. doi: 10.1111/j.1471-4159.2010.06659.x. Epub 2010 Feb 25.

13.

The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis.

Schneider A, Krüger C, Steigleder T, Weber D, Pitzer C, Laage R, Aronowski J, Maurer MH, Gassler N, Mier W, Hasselblatt M, Kollmar R, Schwab S, Sommer C, Bach A, Kuhn HG, Schäbitz WR.

J Clin Invest. 2005 Aug;115(8):2083-98. Epub 2005 Jul 7.

14.
15.

An extended window of opportunity for G-CSF treatment in cerebral ischemia.

Schneider A, Wysocki R, Pitzer C, Krüger C, Laage R, Schwab S, Bach A, Schäbitz WR.

BMC Biol. 2006 Oct 18;4:36.

16.

Systemic G-CSF attenuates cerebral inflammation and hypomyelination but does not reduce seizure burden in preterm sheep exposed to global hypoxia-ischemia.

Jellema RK, Lima Passos V, Ophelders DR, Wolfs TG, Zwanenburg A, De Munter S, Nikiforou M, Collins JJ, Kuypers E, Bos GM, Steinbusch HW, Vanderlocht J, Andriessen P, Germeraad WT, Kramer BW.

Exp Neurol. 2013 Dec;250:293-303. doi: 10.1016/j.expneurol.2013.09.026. Epub 2013 Oct 8.

PMID:
24120465
17.

Successful induction of clinically competent dendritic cells from granulocyte colony-stimulating factor-mobilized monocytes for cancer vaccine therapy.

Ueda Y, Itoh T, Fuji N, Harada S, Fujiki H, Shimizu K, Shiozaki A, Iwamoto A, Shimizu T, Mazda O, Kimura T, Sonoda Y, Taniwaki M, Yamagishi H.

Cancer Immunol Immunother. 2007 Mar;56(3):381-9. Epub 2006 Jul 8.

PMID:
16830156
18.

Anti-P-selectin lectin-EGF domain monoclonal antibody inhibits the maturation of human immature dendritic cells.

Zhou T, Zhang Y, Sun G, Zhang Y, Zhang D, Zhao Y, Chen N.

Exp Mol Pathol. 2006 Apr;80(2):171-6. Epub 2006 Jan 17.

PMID:
16413535
20.

Supplemental Content

Support Center